Weng et al. demonstrated that with modified TZD molecules that no longer bound and activated PPARγ, they could still induce antiproliferative and apoptotic effects on a variety of unrelated cancer cells[23] suggesting that TZDs had anticancer effects unrelated to PPARγ activation. Here, PPARG is linked to cancer.